115 related articles for article (PubMed ID: 6770584)
1. Blood coagulation studies in 45 patients with ischemic cerebrovascular disease and 44 patients with venous thromboembolic disease.
Wahlberg TB; Blombäck M; Overmark I
Acta Med Scand; 1980; 207(5):385-90. PubMed ID: 6770584
[TBL] [Abstract][Full Text] [Related]
2. Value of blood coagulation tests in ischemic cerebral disease.
Norén I; Gårde A
Eur Neurol; 1986; 25(5):330-8. PubMed ID: 2430807
[TBL] [Abstract][Full Text] [Related]
3. Fibronectin and other DIC-related variables in patients with moderately severe infections receiving cryoprecipitate.
Brodin B; Hesselvik F; Blombäck M; Cedergren B; Lieden G; Maller R; Strindberg J
Scand J Clin Lab Invest Suppl; 1985; 178():57-65. PubMed ID: 3937219
[TBL] [Abstract][Full Text] [Related]
4. Venous thrombosis in a family with defective release of vascular plasminogen activator and elevated plasma factor VIII/von Willebrand's factor.
Stead NW; Bauer KA; Kinney TR; Lewis JG; Campbell EE; Shifman MA; Rosenberg RD; Pizzo SV
Am J Med; 1983 Jan; 74(1):33-9. PubMed ID: 6401391
[TBL] [Abstract][Full Text] [Related]
5. Factor VIII related antigen, antithrombin III, spontaneous platelet aggregation and plasminogen activator in ischemic cerebrovascular disease: a study of stroke before 55.
Mettinger KL; Nyman D; Kjellin KG; Sidén A; Söderström CE
J Neurol Sci; 1979 Mar; 41(1):31-8. PubMed ID: 438842
[No Abstract] [Full Text] [Related]
6. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
7. Factors and inhibitors of blood coagulation and fibrinolysis in promyelocytic leukemia.
Bratt G; Blombäck M; Lockner D
Scand J Clin Lab Invest Suppl; 1985; 178():81-3. PubMed ID: 3937221
[No Abstract] [Full Text] [Related]
8. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
Christe M; Fritschi J; Lämmle B; Tran TH; Marbet GA; Berger W; Duckert F
Thromb Haemost; 1984 Oct; 52(2):138-43. PubMed ID: 6084321
[TBL] [Abstract][Full Text] [Related]
9. Coagulation-fibrinolysis system in poststroke patients receiving antiplatelet medication.
Tohgi H; Takahashi H; Chiba K; Tamura K
Stroke; 1993 Jun; 24(6):801-4. PubMed ID: 8506551
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis.
Stegnar M; Bozic B; Peternel P; Kveder T; Vene N; Rozman B
Thromb Res; 1991 Aug; 63(4):433-43. PubMed ID: 1754996
[TBL] [Abstract][Full Text] [Related]
11. Changes in coagulation and fibrinolysis after total hip replacement and their relations with deep vein thrombosis.
Paramo JA; Rocha E
Haemostasis; 1985; 15(5):345-52. PubMed ID: 3935549
[TBL] [Abstract][Full Text] [Related]
12. Inherited hypercoagulable states in children.
Whitlock JA; Janco RL; Phillips JA
Am J Pediatr Hematol Oncol; 1989; 11(2):170-3. PubMed ID: 2526603
[TBL] [Abstract][Full Text] [Related]
13. [Observation of plasma levels of antithrombin-III and plasminogen in acute cerebrovascular disease].
Lu J
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Aug; 22(4):205-7, 252-3. PubMed ID: 2620588
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen, factor VIII related antigen, antithrombin III and alpha 2-antiplasmin in peripheral arterial disease.
Christe M; Delley A; Marbet GA; Biland L; Duckert F
Thromb Haemost; 1984 Dec; 52(3):240-2. PubMed ID: 6442467
[TBL] [Abstract][Full Text] [Related]
15. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK
Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786
[TBL] [Abstract][Full Text] [Related]
16. On the significance of antithrombin-III, alpha 2-macroglobulin, alpha 2-antiplasmin, histidine-rich glycoprotein, and protein C in patients with acute myocardial infarction and deep vein thrombosis.
Gram J; Jespersen J
Thromb Haemost; 1985 Aug; 54(2):503-5. PubMed ID: 2417353
[TBL] [Abstract][Full Text] [Related]
17. A study of hemostasis in ischemic cerebrovascular disease: IV. A five year follow-up of some blood coagulation parameters also including fibrinopeptide A, factor XII and prekallikrein.
Mettinger KL
Thromb Res; 1982 Jul; 27(2):155-60. PubMed ID: 6814002
[TBL] [Abstract][Full Text] [Related]
18. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
Gram J
Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
[TBL] [Abstract][Full Text] [Related]
19. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
[TBL] [Abstract][Full Text] [Related]
20. Measurement of antithrombin III, alpha 2-macroglobulin and alpha 1-antitrypsin in patients with deep venous thrombosis and pulmonary embolism.
de Boer AC; van Riel LA; den Ottolander GJ
Thromb Res; 1979; 15(1-2):17-25. PubMed ID: 90398
[No Abstract] [Full Text] [Related]
[Next] [New Search]
